Authors: Canton, T Bohme, GA Boireau, A Bordier, F Mignani, S Jimonet, P Jahn, G Alavijeh, M Stygall, J Roberts, S Brealey, C Vuilhorgne, M Debono, MW Le Guern, S Laville, M Briet, D Roux, M Stutzmann, JM Pratt, J

Citation: T. Canton et al., RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: Synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis, J PHARM EXP, 299(1), 2001, pp. 314-322

Authors: Mailliet, P Laoui, A Bourzat, JD Capet, M Cheve, M Commercon, A Dereu, N LeBrun, A Martin, JP Peyronel, JF Salagnad, C Thompson, F Zucco, M Guitton, JD Pantel, G Bissery, MC Brealey, C Lavayre, J Lelievre, Y Riou, JF Vrignaud, P Duchesne, M Lavelle, F

Citation: P. Mailliet et al., From random screening of chemical libraries to the optimization of FPP-Competitive inhibitors of farnesyltransferase, CANC DRUG, 8, 2001, pp. 115-144